Clinical Trial

Promoting Cognitive Health in Schizophrenia

Study acronym: iCogCA
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to effectively implement virtually-delivered interventions in mental health institutions nationwide to improve the cognitive health of individuals living with schizophrenia. The main objectives are: * To determine the clinical effectiveness of two virtual cognitive health interventions (i.e., Action-Based Cognitive Remediation or MetaCognitive Training). * To evaluate our implementation strategy involving the virtual delivery of cognitive health interventions combined with a digital learning platform to train mental health practitioners. Participants will be assessed for the severity of symptoms, cognitive performance, and overall functioning before and after receiving the intervention. Qualitative interviews will also be conducted with participants and therapists to evaluate the implementation strategies.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-12-19; most recent amendment 2025-02-10.
Status change: Not Yet Recruiting → Recruiting 2023-10-31
Trial Details
NCT Number NCT05661448
Lead Sponsor Douglas Mental Health University Institute
Collaborators: Canadian Institutes of Health Research (CIHR), McGill University
Conditions Schizophrenia, Cognition
Enrollment 390 participants
Start Date 2023-04-15
Primary Completion 2029-08-31 (estimated)
Study Completion 2029-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-12